Switchgrass is a high yielding, low-input intensive, native perennial grass that has been promoted as a major second-generation bioenergy crop. Raw switchgrass is not a readily acceptable feedstock in existing power plants that were built to accommodate coal and peat. The objective of this research was to elucidate some of the characteristics of switchgrass biochar produced via carbonization and to explore its potential use as a solid fuel. Samples were carbonized in a batch reactor under reactor temperatures of 300, 350 and 400 °C for 1, 2 and 3 h residence times. Biochar mass yield and volatile solids decreased from 82.6% to 35.2% and from 72.1% to 43.9%, respectively, by increasing carbonization temperatures from 300 °C to 400 °C and residence times from 1 h to 3 h. Conversely, biochar heating value (HV) and fixed carbon content increased from 17.6 MJ kg and from 22.5% to 44.9%, respectively, under the same conditions. A biomass discoloration index (BDI) was created to quantify changes in biochar colors as affected by the two tested parameters. The maximum BDI of 77% was achieved at a carbonization temperature of 400 °C and a residence time of 3 h. The use of this index could be expanded to quantify biochar characteristics as affected by thermochemical treatments. Carbonized biochar could be considered a high quality solid fuel based on its energy content. OPEN ACCESSEnergies 2014, 7 549
Active lower limb transfemoral prostheses have enabled amputees to perform different locomotion modes such as walking, stair ascent, stair descent, ramp ascent and ramp descent. To achieve seamless mode transitions, these devices either rely on neural information from the amputee's residual limbs or sensors attached to the prosthesis to identify the intended locomotion modes or both. We present an approach for classification of locomotion modes based on the framework of muscle synergies underlying electromyography signals. Neural information at the critical instances (e.g., heel contact and toe-off) was decoded for this purpose. Non-negative matrix factorization was used to extract the muscles synergies from the muscle feature matrix. The estimation of the neural command was done using non-negative least squares. The muscle synergy approach was compared with linear discriminant analysis (LDA), support vector machine (SVM), and neural network (NN) and was tested on seven able-bodied subjects. There was no significant difference ( p > 0.05 ) in transitional and steady state classification errors during stance phase. The muscle synergy approach performed significantly better ( ) than NN and LDA during swing phase while results were similar to SVM. These results suggest that the muscle synergy approach can be used to discriminate between locomotion modes involving transitions.
Heel ulceration, most frequently the result of prolonged pressure because of patient immobility, can range from the trivial to the life threatening. Whilst the vast majority of heel pressure ulcers (PUs) are superficial and involve the skin (stages I and II) or underlying fat (stage III), between 10% and 20% will involve deeper tissues, either muscle, tendon or bone (stage IV). These stage IV heel PUs represent a major health and economic burden and can be difficult to treat. The worst outcomes are seen in those with large ulcers, compromised peripheral arterial supply, osteomyelitis and associated comorbidities. Whilst the mainstay of management of stage I-III heel pressure ulceration centres on offloading and appropriate wound care, successful healing in stage IV PUs is often only possible with surgical intervention. Such intervention includes simple debridement, partial or total calcanectomy, arterial revascularisation in the context of coexisting peripheral vascular disease or using free tissue flaps. Amputation may be required for failed surgical intervention, or as a definitive first-line procedure in certain high-risk or poor prognosis patient groups. This review provides an overview of heel PUs, alongside a comprehensive literature review detailing the surgical interventions available when managing such patients.
Superhydrophobic surfaces are found in nature and possess several fascinating properties, including the ability to self-clean. A typical superhydrophobic surface has micro/nanostructure roughness and low surface energy, which combine to give it its unusual anti-wetting properties. Because of their unique capabilities, these surfaces have interested scientists in research and industry fields for years. In recent decades, researchers have developed a number of synthetic methods for producing novel superhydrophobic surfaces that mimic natural surfaces. These synthetic surfaces have been widely applied on different types of substrates for potential widespread, practical applications. This review article focuses on these advances in fabricating manmade superhydrophobic surfaces.
Chronic pain is very difficult to treat. Thus, novel analgesics are a critical area of research. Strong pre-clinical evidence supports the analgesic effects of α-conopeptides, Vc1.1 and RgIA, which block α9α10 nicotinic acetylcholine receptors (nAChRs). However, the analgesic mechanism is controversial. Some evidence supports the block of α9α10 nAChRs as an analgesic mechanism, while other evidence supports the inhibition of N-type CaV (CaV2.2) current via activation of GABAB receptors. Here we reassess the effect of Vc1.1 and RgIA on CaV current in rat sensory neurons. Unlike the previous findings, we found highly variable effects among individual sensory neurons, but on average only minimal inhibition induced by Vc1.1, and no significant effect on the current by RgIA. We also investigated the potential involvement of GABAB receptors in the Vc1.1 induced inhibition, and found no correlation between the size of CaV current inhibition induced by baclofen (GABAB agonist) vs. that induced by Vc1.1. Thus, GABAB receptors are unlikely to mediate the Vc1.1 induced CaV current inhibition. Based on the present findings, CaV current inhibition in dorsal root ganglia is unlikely to be the predominant mechanism by which either Vc1.1 or RgIA induce analgesia. Significance Statement Better analgesic drugs are desperately needed to help physicians to treat pain. While many pre-clinical studies support the analgesic effects of α-conopeptides, Vc1.1 and RgIA, the mechanism is controversial. The development of improved α-conopeptide analgesics would be greatly facilitated by a complete understanding of the analgesic mechanism. However, we show that we cannot reproduce one of the proposed analgesic mechanisms, which is an irreversible inhibition of CaV current in a majority of sensory neurons.
A six degree-of-freedom thrust sensor was designed, constructed, calibrated, and tested using the labscale hybrid rocket at the University of Arkansas at Little Rock. The system consisted of six independent legs: one parallel to the axis of symmetry of the rocket for main thrust measurement, two vertical legs near the nozzle end of the rocket, one vertical leg near the oxygen input end of the rocket, and two separated horizontal legs near the nozzle end. Each leg was composed of a rotational bearing, a load cell, and a universal joint above and below the load cell. The leg was designed to create point contact along only one direction and minimize the non-axial forces applied to the load cell. With this system, force in each direction and moments for roll, pitch, and yaw can be measured. The system was calibrated and tested using a labscale hybrid rocket using gaseous oxygen and hydroxyl-terminated polybutadiene solid fuel. The thrust stand proved to be stable during calibration tests. Thrust force vector components and roll, pitch, and yaw moments were calculated for test firings with an oxygen mass flow rate range of 0.0174-0.0348 kg s −1 .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.